Amgen to Invest Over $500M in New R&D Center in California, Creating Hundreds of Jobs.
PorAinvest
martes, 2 de septiembre de 2025, 5:37 pm ET1 min de lectura
AMGN--
The expansion of Amgen's headquarters in Thousand Oaks, California, is part of the company's broader strategy to bolster its research and development efforts. The new R&D center is anticipated to be a significant addition to Amgen's existing facilities, which are already a hub for innovative biopharmaceutical research. [2]
According to the company, the new center will be a state-of-the-art facility equipped with the latest technologies and infrastructure necessary for cutting-edge research. The investment is part of Amgen's ongoing commitment to advancing medical science and developing new treatments for various diseases.
This announcement comes at a time when the biotechnology industry is experiencing significant growth and investment. The total US manufacturing pledge by the industry is nearing $300 billion, with Amgen's contribution being a substantial part of this figure. [2]
The creation of hundreds of new jobs at Amgen's Thousand Oaks headquarters is expected to have a positive impact on the local economy. It will not only provide employment opportunities but also contribute to the growth and development of the region.
Amgen's focus on innovation and research is a key factor in its success as a biopharmaceutical company. The new R&D center is anticipated to further strengthen Amgen's position in the industry by enabling it to develop more effective and efficient treatments.
References:
[1] https://seekingalpha.com/news/4491236-amgen-build-new-rd-center-in-california
[2] https://endpoints.news/amgen-to-expand-california-headquarters-with-new-600m-rd-center/
Amgen plans to invest over $500M to build a new R&D center at its Thousand Oaks, California headquarters. The center is expected to create hundreds of jobs in the US.
Amgen (NASDAQ: AMGN) has announced plans to invest over $500 million to build a new science and innovation center at its headquarters in Thousand Oaks, California. This significant investment aims to enhance the company's research and development capabilities and is expected to create hundreds of jobs in the U.S. [1]The expansion of Amgen's headquarters in Thousand Oaks, California, is part of the company's broader strategy to bolster its research and development efforts. The new R&D center is anticipated to be a significant addition to Amgen's existing facilities, which are already a hub for innovative biopharmaceutical research. [2]
According to the company, the new center will be a state-of-the-art facility equipped with the latest technologies and infrastructure necessary for cutting-edge research. The investment is part of Amgen's ongoing commitment to advancing medical science and developing new treatments for various diseases.
This announcement comes at a time when the biotechnology industry is experiencing significant growth and investment. The total US manufacturing pledge by the industry is nearing $300 billion, with Amgen's contribution being a substantial part of this figure. [2]
The creation of hundreds of new jobs at Amgen's Thousand Oaks headquarters is expected to have a positive impact on the local economy. It will not only provide employment opportunities but also contribute to the growth and development of the region.
Amgen's focus on innovation and research is a key factor in its success as a biopharmaceutical company. The new R&D center is anticipated to further strengthen Amgen's position in the industry by enabling it to develop more effective and efficient treatments.
References:
[1] https://seekingalpha.com/news/4491236-amgen-build-new-rd-center-in-california
[2] https://endpoints.news/amgen-to-expand-california-headquarters-with-new-600m-rd-center/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios